COVID delays in IVF treatment has biggest impact on women over 40
Delays to IVF treatment brought about by the COVID-19 pandemic could reduce the amount of live births in women over 40 by almost a quarter. […]
Home »
Diabetes type 2: Dr Zoe Williams discusses high blood sugar risks Type 2 diabetes – a chronic condition whereby blood sugar levels are often unstable […] Hair loss: Dr Ranj discusses causes of male pattern baldness Hair loss can affect anyone from their late teens onwards, yet, despite its universality, it […] WASHINGTON, Dec. 1, 2020 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved Hetlioz […] We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. Christmas tree […] The COVID-19 pandemic continues to cause significant illness and death while treatment options remain limited. St. Jude Children’s Research Hospital scientists have discovered a potential […] 13 November 2020 — GlaxoSmithKline plc (GSK) today announced further progression in its R&D pipeline with presentation of data for linerixibat, an investigational product for […] Coronavirus has infected more than 40 million people around the world and has caused more than a million deaths in less than a year. Moreover, […] As COVID-19 cases begin climbing again in the United States, the possibility arises of a grim moral dilemma: Which patients should be prioritized if medical […] For those with severe inflammation from thyroid eye disease, the treatment options historically are limited and often require surgical removal of some of the bones […]
Diabetes type 2 warning: Try to not eat past 8pm on Christmas day – here’s why
Hair loss treatment: Red clover extract shown to stimulate hair growth in men
FDA Approves Hetlioz (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome
Christmas tree syndrome – do you have it? Six symptoms to watch out for
Scientists identify possible COVID-19 treatment
GSK Presents Phase 2b Data on Linerixibat for the Treatment of Cholestatic Pruritus in Primary Biliary Cholangitis (PBC)
Ongoing treatment with statins reduces COVID-19 mortality by 22% to 25%
How people would choose who gets scarce COVID-19 treatment
Breakthrough treatment for thyroid eye disease